BCR-ABL1 tyrosine kinase inhibitor-associated thyroid dysfunction: A review of cases reported to the FDA Adverse Event Reporting System and published in the literature

MeSH terms

• Adolescent
• Adult
• Aged
• Aged, 80 and over
• Child
• Female
• Fusion Proteins, bcr-abl / antagonists & inhibitors*
• Humans
• Hyperthyroidism* / chemically induced
• Hyperthyroidism* / epidemiology
• Hyperthyroidism* / therapy
• Hypothyroidism* / chemically induced
• Hypothyroidism* / epidemiology
• Hypothyroidism* / therapy
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / drug therapy
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / epidemiology
• Male
• Middle Aged
• Protein Kinase Inhibitors* / adverse effects
• Protein Kinase Inhibitors* / therapeutic use